BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23347215)

  • 21. Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients.
    Marcelin AG; Roque-Afonso AM; Hurtova M; Dupin N; Tulliez M; Sebagh M; Arkoub ZA; Guettier C; Samuel D; Calvez V; Dussaix E
    Liver Transpl; 2004 Feb; 10(2):295-300. PubMed ID: 14762870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa.
    Kasolo FC; Mpabalwani E; Gompels UA
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():847-55. PubMed ID: 9129658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human herpesvirus-6 (HHV-6) and HHV-7 infections in bone marrow transplant recipients.
    Peiris M
    Crit Rev Oncol Hematol; 1999 Dec; 32(3):187-96. PubMed ID: 10633848
    [No Abstract]   [Full Text] [Related]  

  • 24. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
    Murphy C; Hawkes E; Chionh F; Chong G
    J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant Kaposi sarcoma and multicentric Castleman's disease in a heart transplant recipient.
    Patel A; Bishburg E; Zucker M; Tsang P; Nagarakanti S; Sabnani I
    Heart Lung; 2014; 43(6):506-9. PubMed ID: 25169666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi's sarcoma and other manifestations of human herpesvirus 8.
    Geraminejad P; Memar O; Aronson I; Rady PL; Hengge U; Tyring SK
    J Am Acad Dermatol; 2002 Nov; 47(5):641-55; quiz 656-8. PubMed ID: 12399755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow failure associated with human herpesvirus 8 infection after transplantation.
    Luppi M; Barozzi P; Schulz TF; Setti G; Staskus K; Trovato R; Narni F; Donelli A; Maiorana A; Marasca R; Sandrini S; Torelli G
    N Engl J Med; 2000 Nov; 343(19):1378-85. PubMed ID: 11070102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Human herpesvirus type 6 and type 7 in transplant recipients].
    Benito N; Moreno A; Pumarola T; Marcos MA
    Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):424-32. PubMed ID: 14525708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human herpesvirus 6 infection in transplantation.
    Yoshikawa T
    Nagoya J Med Sci; 2001 May; 64(1-2):11-8. PubMed ID: 11486597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human herpesvirus 8, Kaposi's sarcoma, and associated conditions.
    Gandhi M; Greenblatt RM
    Clin Lab Med; 2002 Dec; 22(4):883-910. PubMed ID: 12489286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin diseases associated with human herpesvirus 6, 7, and 8 infection.
    Blauvelt A
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):197-202. PubMed ID: 11924827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic γ Herpesviruses EBV and HHV8 in Kidney Transplantation.
    Le J
    Semin Nephrol; 2016 Sep; 36(5):362-371. PubMed ID: 27772621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human herpesvirus-6 and -7 in transplantation.
    Dockrell DH; Paya CV
    Rev Med Virol; 2001; 11(1):23-36. PubMed ID: 11241800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients.
    Malahe SRK; van Kampen JJA; Manintveld OC; Hoek RAS; den Hoed CM; Baan CC; Kho MML; Verjans GMGM
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.
    Stallone G; Infante B; Grandaliano G; Schena FP; Gesualdo L
    Transpl Int; 2008 Sep; 21(9):825-32. PubMed ID: 18498314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease.
    Ascoli V; Sirianni MC; Mezzaroma I; Mastroianni CM; Vullo V; Andreoni M; Narciso P; Scalzo CC; Nardi F; Pistilli A; Lo Coco F
    Ann Diagn Pathol; 1999 Dec; 3(6):357-63. PubMed ID: 10594287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation.
    Caïola D; Karras A; Flandre P; Boutolleau D; Scieux C; Agut H; Legendre C; Gautheret-Dejean A
    J Med Virol; 2012 Mar; 84(3):450-6. PubMed ID: 22246831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients.
    Clark DA
    Int J Hematol; 2002 Aug; 76 Suppl 2():246-52. PubMed ID: 12430932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
    Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
    J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.